• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket

    8/11/22 7:17:57 AM ET
    $AEG
    $AKAN
    $APP
    $ATNX
    Life Insurance
    Finance
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AEG alert in real time by email

    Gainers

    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 44.6% to $0.2284 in pre-market trading. T2 Biosystems shares jumped over 30% on Wednesday after the company on Tuesday announced it will explore the potential to develop a rapid molecular diagnostic test for monkeypox.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares rose 37.5% to $1.83 in pre-market trading after the company posted a narrower Q2 loss.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) shares rose 36.6% to $0.6210 in pre-market trading. Massachusetts Governor Baker on Wednesday signed the state's sports betting bill into law.
    • Performance Shipping Inc. (NASDAQ:PSHG) rose 32.1% to $0.6801 in pre-market trading after jumping over 25% on Wednesday.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) rose 29% to $4.58 in pre-market trading. Greenwave reported Q2 revenue of $10.7 million.
    • Vacasa, Inc. (NASDAQ:VCSA) shares rose 28% to $3.89 in pre-market trading after posting upbeat quarterly sales.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) rose 26.7% to $18.69 in pre-market trading. The company’s shares jumped 30% on Wednesday after the Redbox shareholders approved the proposed merger agreement.
    • FlexShopper, Inc. (NASDAQ:FPAY) rose 25% to $1.40 in pre-market trading after reporting Q2 results.
    • Timber Pharmaceuticals, Inc. (NYSE:TMBR) shares rose 19.3% to $0.1289 in pre-market trading. Timber Pharmaceuticals recently announced closing of $8.0 million public offering.
    • NewAge, Inc. (NASDAQ:NBEV) rose 19.2% to $0.3184 in pre-market trading.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) rose 15.3% to $0.4690 in pre-market trading.
    • Matterport, Inc. (NASDAQ:MTTR) rose 13.6% to $5.91 in pre-market trading after the company reported better-than-expected Q2 EPS results and issued Q3 and FY22 EPS and sales guidance above estimates.
    • Green Giant Inc. (NASDAQ:GGE) rose 13.3% to $3.66 in pre-market trading after gaining 7% on Wednesday.
    • Tantech Holdings Ltd (NASDAQ:TANH) rose 11.5% to $0.3161 in pre-market trading.
    • KINS Technology Group Inc. (NASDAQ:KINZ) rose 9.8% to $11.00 in pre-market trading.
    • Sky Harbour Group Corporation (NYSE:SKYH) rose 9.5% to $4.77 in pre-market trading after declining over 6% on Wednesday.
    • Aegon N.V. (NYSE:AEG) rose 7.8% to $5.00 in pre-market trading after the company increased its projections for operating capital generation and free cashflow.
    • PolarityTE, Inc. (NASDAQ:PTE) rose 7.7% to $1.68 in pre-market trading. The company is scheduled to release quarterly earnings after the closing bell.
    • The Walt Disney Company (NYSE:DIS) rose 7.5% to $120.82 in pre-market trading after the company reported better-than-expected Q3 EPS and sales results.
    • Enovix Corporation (NASDAQ:ENVX) rose 6.6% to $17.21 in pre-market trading following Q2 results.
    • Coupang, Inc. (NYSE:CPNG) rose 6.2% to $20.98 in pre-market trading after the company reported second-quarter revenue growth of 12.5% year-over-year to $5.04 billion, +27% on a constant currency basis.
    • H&R Block, Inc. (NYSE:HRB) shares rose 4% to $47.30 in pre-market trading. H&R Block recently said Q4 sales results were higher year over year.

     

    Don’t forget to check out our premarket coverage here .

    Losers

    • Athenex, Inc. (NASDAQ:ATNX) shares fell 23.4% to $0.8505 in pre-market trading after the company reported pricing of $30 million public offering of common stock and warrants.
    • Sonos, Inc. (NASDAQ:SONO) shares fell 20.4% to $18.11 in pre-market trading after the company reported weaker-than-expected sales results for its third quarter and issued downbeat FY22 sales guidance. The company also announced that its CFO Brittany Bagley is stepping down to pursue another professional opportunity. Eddie Lazarus, the company's chief legal officer, will succeed Bagley as interim CFO, effective Sept. 1.
    • Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) fell 19.1% to $0.85 in pre-market trading after jumping over 10% on Wednesday.
    • Invitae Corporation (NYSE:NVTA) shares fell 18.9% to $7.00 in pre-market trading. Invitae shares jumped around 277% on Wednesday after the company reported better-than-expected Q2 EPS results.
    • Hyperfine, Inc. (NASDAQ:HYPR) fell 14.4% to $1.59 in pre-market trading after the company posted downbeat Q2 results and issued weak FY22 revenue forecast.
    • Palisade Bio, Inc. (NASDAQ:PALI) fell 12.4% to $0.2889 in pre-market trading after declining over 18% on Wednesday.
    • Traeger, Inc. (NYSE:COOK) fell 12.2% to $3.51 in pre-market trading after the company reported worse-than-expected Q2 EPS and sales results and reduced FY22 sales guidance below estimates.
    • Ensysce Biosciences, Inc. (NASDAQ:ENSC) fell 12% to $0.47 in pre-market trading. Ensysce Biosciences reported completion of $8 million convertible note financing.
    • Akanda Corp. (NASDAQ:AKAN) fell 9.3% to $1.07 in pre-market trading after declining around 6% on Wednesday.
    • Iveda Solutions, Inc. (NASDAQ:IVDA) fell 8.7% to $1.24 in pre-market trading. Iveda Solutions recently reported a $5 million private placement.
    • Pan American Silver Corp. (NASDAQ:PAAS) shares fell 8.6% to $19.25 in pre-market trading after the company reported Q2 results.
    • Bumble Inc. (NASDAQ:BMBL) fell 8.5% to $31.55 in pre-market trading after the company reported worse-than-expected Q2 EPS results and issued Q3 and FY22 sales guidance below estimates.
    • AppLovin Corporation (NASDAQ:APP) fell 7.8% to $37.30 in pre-market trading after the company reported Q2 EPS results were down year over year and worse-than-expected Q2 sales results and lowered FY22 sales guidance below estimates.
    • Ontrak, Inc. (NASDAQ:OTRK) fell 6.9% to $0.75 in pre-market trading after the company posted downbeat quarterly sales and issued weak sales forecast.
    • Haleon plc (NYSE:HLN) fell 6% to $6.12 in pre-market trading after dropping over 8% on Wednesday.
    • Sanofi (NASDAQ:SNY) fell 5.7% to $42.62 in pre-market trading. The company on Monday announced it will pause recruitment for Phase 3 studies for its MS drug tolebrutinib.
    • Marqeta, Inc. (NASDAQ:MQ) fell 5.6% to $10.43 in pre-market trading after the company reported financial results for the second quarter.
    • Broadstone Net Lease, Inc. (NYSE:BNL) fell 5.1% to $21.25 in pre-market trading as the company priced 13 million share public offering of common stock at $21.35 per share.
    Get the next $AEG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEG
    $AKAN
    $APP
    $ATNX

    CompanyDatePrice TargetRatingAnalyst
    Marqeta Inc.
    $MQ
    2/17/2026$6.00Overweight
    Analyst
    Sanofi
    $SNY
    2/12/2026Buy → Neutral
    BofA Securities
    Coupang Inc.
    $CPNG
    2/5/2026$17.00Underperform
    Bernstein
    Walt Disney Company
    $DIS
    2/3/2026$135.00Overweight
    Morgan Stanley
    Sanofi
    $SNY
    1/27/2026Neutral
    Citigroup
    Applovin Corporation
    $APP
    1/26/2026$700.00Hold → Buy
    Needham
    Haleon plc
    $HLN
    1/23/2026Equal Weight → Overweight
    Barclays
    Sanofi
    $SNY
    1/16/2026Buy → Neutral
    UBS
    More analyst ratings

    $AEG
    $AKAN
    $APP
    $ATNX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EXL and AWS collaborate on agentic AI initiative to reshape Sonos IT service management

    NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- EXL (NASDAQ:EXLS), a global data and AI company, today announced a critical transformation initiative with Sonos (NASDAQ:SONO), the world's leading sound experience company, and Amazon Web Services (AWS). This unique collaboration deploys agentic AI within Sonos IT service management (ITSM) workflows, aiming to create a new benchmark for efficiency, operational intelligence and risk mitigation. The initiative brings together Sonos innovative culture, EXL's deep expertise in AI-led solutions and the powerful cloud infrastructure of AWS. The initiative represents a significant step forward in applying sophisticated AI to real-world enterprise scen

    2/23/26 11:47:03 AM ET
    $EXLS
    $SONO
    Real Estate
    Consumer Electronics/Appliances
    Consumer Staples

    Palisade Bio Reports Rapid Clinical, Histologic and New Mechanistic Colon Tissue RNA Sequencing Data Supporting Targeted Activity of PALI-2108 at ECCO 2026

    Phase 1b translational data demonstrate localized ileocolonic target engagement, suppression of inflammatory and fibrotic gene programs, and early clinical response within seven days Encouraging safety profile across 89 subjects supports differentiated, colon-targeted PDE4 approach Translational analyses confirm local suppression of TNF-α, JAK–STAT, NF-κB, MAPK and TGF-β signaling in colon tissue with minimal peripheral immune modulation Data presented at the 21st Congress of the European Crohn's and Colitis Organization (ECCO) in Stockholm, Sweden Carlsbad, CA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmac

    2/23/26 8:40:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Traeger Announces Reporting Date for Fourth Quarter and Full Year 2025 Financial Results

    Traeger, Inc. ("Traeger") (NYSE:COOK), creator and category leader of the wood pellet grill, today announced that it will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Management will host a conference call at 4:30 p.m. Eastern Time to discuss its financial results. Those who wish to participate in the call may do so by dialing (833) 470-1428 or +1 (646) 844-6383 for international callers, conference ID 589715. To pre-register for the conference call, please visit Traeger Fourth Quarter and Full Year 2025 Earnings Conference Call. The conference call will also be webcast live at https://investors.traeger.com. For those una

    2/19/26 4:05:00 PM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    $AEG
    $AKAN
    $APP
    $ATNX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEG
    $AKAN
    $APP
    $ATNX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Coliseum Capital Management, Llc bought $10,180,585 worth of shares (647,210 units at $15.73) (SEC Form 4)

    4 - Sonos Inc (0001314727) (Issuer)

    2/17/26 9:00:43 PM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    Director Chang Amy bought $98,791 worth of Disney Common Stock (916 units at $107.85), increasing direct ownership by 7% to 14,720 units (SEC Form 4)

    4 - Walt Disney Co (0001744489) (Issuer)

    2/17/26 6:07:20 PM ET
    $DIS
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Large owner Coliseum Capital Management, Llc bought $11,556,296 worth of shares (733,073 units at $15.76) (SEC Form 4)

    4 - Sonos Inc (0001314727) (Issuer)

    2/6/26 7:05:20 PM ET
    $SONO
    Consumer Electronics/Appliances
    Consumer Staples

    $AEG
    $AKAN
    $APP
    $ATNX
    SEC Filings

    View All

    SEC Form 6-K filed by Sanofi

    6-K - Sanofi (0001121404) (Filer)

    2/23/26 9:19:13 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Broadstone Net Lease Inc.

    10-K - Broadstone Net Lease, Inc. (0001424182) (Filer)

    2/19/26 4:38:36 PM ET
    $BNL
    Real Estate Investment Trusts
    Real Estate

    SEC Form 10-K filed by Applovin Corporation

    10-K - AppLovin Corp (0001751008) (Filer)

    2/19/26 4:02:51 PM ET
    $APP
    Computer Software: Programming Data Processing
    Technology

    $AEG
    $AKAN
    $APP
    $ATNX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Gonzalez Francisco was granted 203,390 shares and covered exercise/tax liability with 15,320 shares, increasing direct ownership by 36% to 709,588 units (SEC Form 4)

    4 - Sky Harbour Group Corp (0001823587) (Issuer)

    2/20/26 8:14:41 PM ET
    $SKYH
    Real Estate
    Finance

    Chief Executive Officer Keinan Tal was granted 225,989 shares and covered exercise/tax liability with 6,445 shares, increasing direct ownership by 436% to 269,846 units (SEC Form 4)

    4 - Sky Harbour Group Corp (0001823587) (Issuer)

    2/20/26 8:14:03 PM ET
    $SKYH
    Real Estate
    Finance

    Chief Accounting Officer Schmitt Michael Weber was granted 33,898 shares and covered exercise/tax liability with 3,011 shares, increasing direct ownership by 59% to 83,441 units (SEC Form 4)

    4 - Sky Harbour Group Corp (0001823587) (Issuer)

    2/20/26 8:13:06 PM ET
    $SKYH
    Real Estate
    Finance

    $AEG
    $AKAN
    $APP
    $ATNX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Marqeta with a new price target

    Analyst resumed coverage of Marqeta with a rating of Overweight and set a new price target of $6.00

    2/17/26 7:51:08 AM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Sanofi downgraded by BofA Securities

    BofA Securities downgraded Sanofi from Buy to Neutral

    2/12/26 7:23:56 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bernstein initiated coverage on Coupang with a new price target

    Bernstein initiated coverage of Coupang with a rating of Underperform and set a new price target of $17.00

    2/5/26 6:56:49 AM ET
    $CPNG
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AEG
    $AKAN
    $APP
    $ATNX
    Leadership Updates

    Live Leadership Updates

    View All

    Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board

    Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026 Carlsbad, CA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (NASDAQ:PALI) ("Palisade" or the "Company"), a clinical-stage biopharmaceutical company advancing next-generation, once-daily oral PDE4 inhibitor prodrugs engineered for targeted delivery to the terminal ileum and colon, today announced the appointment of Bram Verstockt, MD, PhD, to its Clinical Advisory Board (CAB). Dr. Verstockt is an internationally recognized expert in inflammatory bowel disease (IBD) and a leader in precisi

    2/17/26 8:45:00 AM ET
    $PALI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Sanofi announces leadership evolution in Specialty Care Business Unit

    CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has decided to leave the company as of February 28, 2026, having accepted an external leadership opportunity. Brian joined Sanofi in 2017 and has held several senior leadership roles, most recently leading the Specialty Care Global Business Unit and serving as a member of the Executive Committee. During his tenure, Sanofi's Specialty Care strengthened its global position, driven by the launches of key medicines such as Dupixent across multiple indications and geographies. Manuela will lead Sanofi's Spe

    2/17/26 8:30:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    $AEG
    $AKAN
    $APP
    $ATNX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Greenwave Technology Solutions Inc.

    SC 13G - Greenwave Technology Solutions, Inc. (0001589149) (Subject)

    12/5/24 10:00:25 AM ET
    $GWAV
    Metal Fabrications
    Industrials

    Amendment: SEC Form SC 13G/A filed by Marqeta Inc.

    SC 13G/A - Marqeta, Inc. (0001522540) (Subject)

    11/27/24 8:47:26 PM ET
    $MQ
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Citius Pharmaceuticals Inc.

    SC 13D/A - Citius Pharmaceuticals, Inc. (0001506251) (Subject)

    11/27/24 4:05:31 PM ET
    $CTXR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEG
    $AKAN
    $APP
    $ATNX
    Financials

    Live finance-specific insights

    View All

    Traeger Announces Reporting Date for Fourth Quarter and Full Year 2025 Financial Results

    Traeger, Inc. ("Traeger") (NYSE:COOK), creator and category leader of the wood pellet grill, today announced that it will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Management will host a conference call at 4:30 p.m. Eastern Time to discuss its financial results. Those who wish to participate in the call may do so by dialing (833) 470-1428 or +1 (646) 844-6383 for international callers, conference ID 589715. To pre-register for the conference call, please visit Traeger Fourth Quarter and Full Year 2025 Earnings Conference Call. The conference call will also be webcast live at https://investors.traeger.com. For those una

    2/19/26 4:05:00 PM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    Bumble Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 11, 2026

    Bumble Inc. (NASDAQ:BMBL) today announced that it will report financial results for the fourth quarter and full year ending December 31, 2025, following the close of market on Wednesday, March 11, 2026. The Company will host a live webcast of its conference call to discuss the results at 4:30 p.m. Eastern Time on that day. The webcast of the call, the earnings release, and any related materials will be accessible on the Investors section of the Company's website at https://ir.bumble.com. A webcast replay will be available approximately two hours after the conclusion of the live event. About Bumble Inc. Bumble Inc. is the parent company of Bumble, Badoo and BFF. Bumble brings people cl

    2/19/26 4:05:00 PM ET
    $BMBL
    Computer Software: Programming Data Processing
    Technology

    Six Years of Silver Deficits: Here Are Five Companies Holding Real Ounces

    VANCOUVER, British Columbia, Feb. 19, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The silver market is heading for its sixth consecutive annual supply deficit in 2026, with cumulative shortfalls now exceeding 800 million ounces over the past five years, roughly equivalent to an entire year of global mine production.[1] Industrial demand from solar panels, electric vehicles, and semiconductor manufacturing continues to outstrip new supply at a pace the market has not seen in modern history.[2] Five companies are positioned to benefit from this structural imbalance: Americore Resources (TSXV:AMCO) (OTCQB:AMCOF), Wheaton Precious Metals (NYSE:WPM) (TSX:WPM), Hecla Mining (NYSE

    2/19/26 9:10:00 AM ET
    $HL
    $PAAS
    $UAMY
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials
    Precious Metals
    Basic Materials